National Institute for Health and Care Research logo
National Institute for Health and Care Research

Interventions for school-aged children with a developmental stammer

Funds a UK trial of therapy for school-aged children who stammer and want treatment.

This call funds a single study, not a portfolio of parallel projects, so competing proposals are directly weighed against each other rather than spread across multiple winners. Peer reviewers and the funding committee explicitly judge applications on value for money, and the scale of justification you provide is expected to match the size of the budget you are asking for. The intervention itself h

The HTA Programme wants a commissioned study testing the clinical and cost-effectiveness of an intervention for school-aged children with a developmental stammer who want therapy. Applicants must define their own target-age criteria and comparator, and are asked to consider children with common comorbidities such as ADHD and those for whom English is not a first language. The study must build on, or explain how it accounts for, any previous stammering therapy participants may have had.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.18 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
King's College London — King's Innovation Catalyst (IP & Licensing) logo
Open

Innovation Development Award

🇬🇧KCL Innovation Catalyst · United Kingdom

Funds King's College London researcher innovations advancing toward commercial application.

BiotechMedtech+2
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

🇪🇺European Commission · European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
€10MApr'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

🇪🇺European Commission · European Union

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
€7M – €8MApr'27
European Commission logo
Scheduled

Prevention and management of chronic non-communicable diseases in children and young people

🇪🇺European Commission · European Union

Funds implementation research that helps children and young people prevent and manage chronic disease equitably.

MedtechBiotech
€3M – €4MApr'27
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

🇪🇺European Commission · European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
€6M – €8MApr'27
Multiple Sclerosis Society UK logo
Open

MS Society Skills Development Awards

🇬🇧MS Society UK · United Kingdom

Provides short grants for early career researchers building advanced multiple sclerosis skills in the United Kingdom.

BiotechMedtech+1
£2K